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Abstract
The enormous toll on human life during the 1918–1919 Spanish influenza pandemic is a constant reminder of the potential
lethality of influenza viruses. With the declaration by the World Health Organization of a new H1N1 influenza virus
pandemic, and with continued human cases of highly pathogenic H5N1 avian influenza virus infection, a better
understanding of the host response to highly pathogenic influenza viruses is essential. To this end, we compared pathology
and global gene expression profiles in bronchial tissue from macaques infected with either the reconstructed 1918
pandemic virus or the highly pathogenic avian H5N1 virus A/Vietnam/1203/04. Severe pathology was observed in
respiratory tissues from 1918 virus-infected animals as early as 12 hours after infection, and pathology steadily increased at
later time points. Although tissues from animals infected with A/Vietnam/1203/04 also showed clear signs of pathology
early on, less pathology was observed at later time points, and there was evidence of tissue repair. Global transcriptional
profiles revealed that specific groups of genes associated with inflammation and cell death were up-regulated in bronchial
tissues from animals infected with the 1918 virus but down-regulated in animals infected with A/Vietnam/1203/04.
Importantly, the 1918 virus up-regulated key components of the inflammasome, NLRP3 and IL-1b, whereas these genes
were down-regulated by A/Vietnam/1203/04 early after infection. TUNEL assays revealed that both viruses elicited an
apoptotic response in lungs and bronchi, although the response occurred earlier during 1918 virus infection. Our findings
suggest that the severity of disease in 1918 virus-infected macaques is a consequence of the early up-regulation of cell
death and inflammatory related genes, in which additive or synergistic effects likely dictate the severity of tissue damage.
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Introduction
Influenza virus causes over 36,000 deaths [1] and 1.68 million
hospitalizations in the United States every year [2]. However, the
potential of this virus to disrupt society is best evidenced by the
1918–1919 influenza pandemic, which resulted in over 50 million
deaths worldwide. The circulation of highly pathogenic avian
H5N1 strains in Asia, and reports of their sporadic human-to-
human transmission [3,4], has raised concern over the potential
for a deadly new influenza pandemic. Presently, a novel swine-
origin influenza A (H1N1) virus (S-OIV) is spreading rapidly
among humans, presenting the greatest threat since the emergence
of influenza A (H3N2) virus in 1968 [5]. Although the World
Health Organization has recently declared the first pandemic of
the new millennium caused by this new S-OIV, initial analyses
suggest that the clinical severity associated with the H1N1 virus is
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current as well as future pandemics will require a better
understanding of the host response to influenza virus infection,
including mechanisms of viral pathogenesis and interactions with
the host machinery, which will facilitate efforts to develop safe and
effective therapeutics and vaccines.
Traditionally, studies of influenza virus pathogenesis compare
viruses of high and low pathogenicity [7,8]; nonetheless,
comparisons of highly pathogenic strains are necessary to
determine commonalities and differences in the host response
and to develop effective countermeasures. Results from indepen-
dent studies using macaque infection models suggest there are
differences in lethality and disease progression between the 1918
and H5N1 viruses [8,9]. In particular, infection with the 1918
virus leads to severe disease and death, whereas animals infected
with VN/1203/04, an H5N1 avian virus, typically recover from
infection. We have previously shown that an atypical host innate
immune response may contribute to the severity of disease and
fatal outcome in 1918-virus infected macaques [8]. Additional
studies have suggested that early events during infection may be
critical for disease outcome [10]. Microarray studies of H1N1 (A/
Texas/36/91) influenza virus-infected pigtailed macaques (Macaca
nemestrina) [11,12] indicate that activation of inflammatory cells
and apoptotic pathways correlates with tissue damage during
infection.
In the present study, we examined two highly pathogenic
influenza viruses, the fully reconstructed human H1N1 ‘‘Spanish
flu’’ 1918 virus (1918) [8] and the highly pathogenic avian H5N1
A/Vietnam/1203/04 virus (VN/1203) in macaques (Macaca
fascicularis), an established model for influenza virus infection
[13,14]. The Influenza A genome consists of eight gene segments
designated PB2, PB1, PA, HA, NP, NA, M, and NS. The identities
of these genes between 1918 and VN/1203 virus are 84, 84, 86,
63, 86, 82, 90, and 89%, respectively. We found specific
differences in gene expression in the bronchus of animals infected
with the 1918 virus compared with those infected with VN/1203,
with the largest differences in expression occurring at 24 h after
infection. Biochemical assays showed that both viruses elicited an
apoptotic response in lungs and bronchi, although the response
occurred earlier during 1918 virus infection. These results suggest
that the differential regulation of genes associated with specific
biological functions, including cell death and inflammation, are
associated with increased severity of disease caused by the 1918
virus.
Materials and Methods
Ethics statement
All animal experiments were performed under an approved
animal-use document and according to the guidelines of the
Canadian Council on Animal Care.
Viruses
The highly pathogenic H5N1 virus used in this study (A/
Vietnam/1203/04) was kindly provided by the Centers for
Disease Control and Prevention. Genes of the 1918 virus
(GenBank DQ208309, DQ208310, DQ208311, AF117241,
AY744935, AF250356, AY130766, AF233238) were constructed
with the 59 and 39 non-coding sequences of A/WSN/33 (H1N1)
and cloned into plasmid vector pPolI, as previously described [15].
The 1918 virus was generated by reverse genetics [16], and titered
stocks were prepared [15], as previously described. Forty-eight
hours post-transfection, viruses were harvested and used to
inoculate MDCK cells for the production of stock viruses. Eight
genes of each transfectant virus were partially sequenced to
confirm the origin of the gene.
Macaque experiments
The macaques (Macaca fascicularis) used in this study were
inoculated by intratracheal (4 ml), intranasal (0.5 ml/nostril),
intraocular (0.5 ml/eye) and oral (1 ml) routes with a suspension
containing 10
6 plaque-forming units (PFU) per ml for a total
infectious dose by all routes of 7610
6 PFU. Six animals received
the 1918 virus and were euthanized at 12, 24, or 48 h post
infection (2 animals per time point). Eleven animals received the
A/Vietnam/1203/04 virus and were euthanized at 12, 24, or 48 h
or at 3 or 6 days post-infection (2 animals per time point). A single
animal infected with A/Vietnam/1203/04 was euthanized at day
16. Viral titers in bronchus were quantified by standard plaque
assay in MDCK cells. Tissue samples were placed in RNA Later
(Ambion) for subsequent RNA extraction (Qiagen RNA Later kit).
Histopathology
The tissues were fixed in 10% neutralized phosphate-buffered
formalin. Fixed tissues were dehydrated, embedded in paraffin,
and cut into 5-mm-thick sections and then stained with standard
haematoxylin and eosin. For viral antigen detection, sections were
processed for immunostaining by the two-step dextran polymer
method (DAKO), with a rabbit polyclonal antibody to A/WSN/
33 (H1N1) used as the primary antibody.
Virus titrations of nonhuman primate tissues and swabs
Tissue homogenates were prepared in minimal essential
medium supplemented with 0.1% bovine serum albumin and
antibiotics (MEM/BSA) by using a bead mill homogenizer
(Qiagen Tissuelyser) at 30 Hz for 5 min. Tissue debris was
pelleted by centrifugation (20006 g, 5 min) and virus titers were
determined in 10-fold serial dilutions by standard plaque assay on
Madin Darby canine kidney (MDCK) cells in the presence of
1 mg/ml tosyl phenylalanyl chloromethyl ketone (TPCK)-treated
trypsin, in duplicate for each dilution. Virus in swabs was similarly
Author Summary
The world is currently experiencing a pandemic caused by
a new type of H1N1 influenza virus that originated in
swine. Although it is too early to tell how virulent this new
virus may be, some influenza viruses can cause severe
disease. The 1918 pandemic, also caused by an H1N1 virus,
resulted in over 50 million deaths worldwide. Highly
pathogenic avian H5N1 influenza viruses are circulating in
several parts of the world, and although human infection
has been rare, the virus often causes a lethal illness. To
determine whether highly pathogenic influenza viruses
cause disease by similar means, we used a macaque
infection model to study the host response to the
reconstructed 1918 virus and an avian H5N1 isolate known
as VN/1203. We found that although both viruses caused
severe disease, infection with the 1918 virus was more
likely to result in death, whereas animals infected with VN/
1203 recovered from infection. In animals infected with the
1918 virus, there was increased expression of genes
associated with inflammation, and these genes were
turned on as early as 12 hours after infection. Drugs that
limit the early inflammatory response may therefore be of
benefit in treating infections caused by highly pathogenic
influenza viruses.
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suspension medium.
Microarray analysis and bioinformatics
Separate microarrays were run for each experimental sample (one
sample per animal and two animals per time point). Equal masses of
total RNA isolated from bronchi collected from infected macaques
were amplified with a Low RNA Input Linear Amplification Kit
(Agilent Technology) according to the manufacturer’s instructions.
Global gene expression in infected bronchi was compared to pooled
RNA prepared from equal masses of total RNA from bronchi tissue of
six uninfected macaques. Probe labeling and microarray slide
hybridization were performed as described elsewhere [17] with
custom rhesus macaque (Macaca mulatta) oligonucleotide microarrays
containing 22,000 rhesus probes corresponding to 18,000 unique
rhesus genes (designed in collaboration with Agilent Technologies).
Raw microarray image files were processed using Feature Extraction
8.1 software (Agilent Technologies) and entered into a custom-
designed relational database (Expression Array Manager). We
processed and analyzed the expression data using the limma package
forthe Rprogramming environment [18].Background correctionwas
performed by using limma’s ‘‘normexp’’ method, which ensures that
there were no missing or negative corrected intensities. An offset of 50
was used for both channels to damp down the variability of the log-
ratios for low-intensity spots. The resulting log-ratios were normalized
by using ‘loess’’ methods. Between –array normalization was achieved
by using limma’s ‘‘Aquantile’’ method, which does quantile
normalization of mean probe intensity values. The normalized
expression data were analyzed together by using linear model
methods. A batch factor was included in the linear model to remove
potential batch effects. Differential expression was assessed by using
moderated t-statistics. Primary data is available at http://viromics.
washington.edu in accordance with proposed MIAME standards.
Functional and network analysis of statistically significant gene
expression changes was performed with Ingenuity Pathways
Analysis 7.1 (Ingenuity Systems). Genes from the data set that
met the twofold (P,0.01) change cutoff and were associated with
biological functions in the Ingenuity Pathways Knowledge Base
were considered for analysis. For all analyses, Fisher’s exact test
was used to calculate a P-value determining the probability that
each biological function assigned to that data set was due to
chance alone. In the functional network shown in this paper, genes
are represented as nodes, and the biological relationship between
two nodes is represented as an edge (line). All edges are supported
by at least one published reference or from canonical information
stored in the Ingenuity Pathways Knowledge Base. For these
analyses, Fisher’s exact test was used to calculate a P-value
determining the probability that each biological function and/or
disease assigned to that data set was due to chance alone.
Quantitative real-time RT-PCR
RT-PCR was performed to validate cellular gene expression
changes as detected with microarrays. The QuantiTect reverse
transcription kit (Qiagen Inc., Valencia, CA) was used to generate
cDNA. qRT-PCR was run on the ABI 7500 PCR system, using
TaqMan chemistry (Applied Biosystems, Foster City, CA). Gene
expression assays specific to Rhesus cellular genes were purchased
from Applied Biosystems. Differences in gene expression are
represented as Log10RQ relative to a calibrator and normalized to
a reference, using the 2
2DDCt method [19].
TUNEL assay
Lung and bronchus tissues were fixed in 10% neutralized
phosphate-buffered formalin. Fixed tissues were dehydrated,
embedded in paraffin, cut into 5 mm-thick sections, and then
processed for TUNEL assay (X2044K2. ApoMark
TM DNA
Fragmentation Detection Kit. The Exalpha Biologicals, Inc.,
Maymard, MA). Briefly, the sections were rehydrated and
permeabilized using Proteinase K solution. Endogenous peroxi-
dases were inactivated with 3% hydrogen peroxide in methanol.
After terminal deoxynucleotidyl transferase (TdT) reaction,
biotinylated dUTP were visualized using HRP-conjugated strep-
tavidin and 3.39-Diamino benzidine (DAB). The sections were
counterstained with methyl green solution.
Biocontainment
All in vitro and in vivo procedures with the 1918 and VN/1203
influenza viruses were performed in the biosafety level 4 facility of the
National Microbiology Laboratory of the Public Health Agency,
Canada. Prior to removal from BSL4, all specimens were inactivated
using Standard Operating Protocols and verified to be noninfectious.
Results
The 1918 virus causes greater early tissue damage than
VN/1203
We previously used a macaque infection model to examine the
host response to the reconstructed 1918 virus at 3, 6, and 8 days
after infection [8]. That study revealed that the 1918 virus caused
a severe respiratory infection that culminated in acute respiratory
failure and a fatal outcome. In addition, our histopathology and
gene expression analyses suggested that events occurring well
before the 3-day time point may have a critical influence on the
course of disease progression. Furthermore, Baskin et al. [9]
compared the host response to VN/1203 and A/Texas/36/91
containing two (HA and NA) or three (HA, NA and NS) genes
from the 1918 pandemic virus in a macaque model at 1, 2, 4 and 7
days after infection. That study indicated that tissue damage
induced by VN/1203 was the result of multiple factors such as an
excessive and sustained type I interferon response and the
deregulation of adaptive responses. In the present study, we
sought to evaluate the host response at earlier time points after
infection and to directly compare the host transcriptional response
to these two highly pathogenic influenza viruses.
Animals infected with the 1918 virus or with VN/1203 were
euthanized at 12, 24, or 48 h post-infection (p.i.). An additional
group of animals infected with VN/1203 were euthanized at 3, 6,
or 16 days p.i. Histopathology revealed that at 12 h p.i., the 1918
and VN/1203 viruses had already begun to cause pathology, and
viral antigen was detected along the terminal and respiratory
bronchiole (Figure S1). By 24 h p.i., antigen detection and severity
of disease were more robust in the 1918-virus infected macaques,
and the peribronchiolar alveoli showed severe alveolitis, edema,
and hemorrhage (Figure 1, A). Additionally, the virus was widely
distributed in bronchi and alveoli (Figure 1, C, E). This phenotype
was lacking in macaques infected with VN/1203 (Figure 1, B, D,
F). By 48 h p.i., the histopathology associated with 1918 and VN/
1203 infection was similar, with clear alveolitis and alveolar edema
around the bronchiole. Although the number of cells positive for
viral antigen decreased in the edematous lesion, positive cells were
still detected at the edematous lesion boundary (Figure S2). At
later time points (days 3, 6, and 16), cells positive for viral antigen
decreased in number in VN/1203-infected animals and by day 16
the lung showed prominent peribronchiolar lymph follicle
development and tissue regeneration (Figure 2).
Analysis of viral titer revealed that at 12 h p.i., the titer of the
1918 virus appeared somewhat higher than the VN/1203 virus;
whereas at 24 h p.i., titers for the two viruses were more similar
Genomic Analysis of 1918 and H5N1 Influenza Virus
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viruses at the 48-h time point. Whereas we previously observed
that the titer of the 1918 virus increased steadily at later time
points (3, 6, and 8 days post infection) [8], VN/1203 titers did not
increase after the 24-h time point and remained essentially
constant at 3 and 6 days post infection (Figure 3). Thus, although
1918 and VN/1203 titers were similar at the 24-h time point, the
1918 virus had already caused greater pathology, which continued
to worsen over time. In contrast, VN/1203 titers began to
decrease after 24 h, and pathology began to diminish. These
results suggest that macaques were able to mount a successful
initial nonspecific innate response to both viruses as demonstrated
by the similar decrease in titers during the 24–48 hour period.
However, the 1918 virus appears to be able to overcome the host
response and replicate at high levels [8], whereas VN/1203
replication was limited by the host response.
The 1918 and VN/1203 viruses elicit similar interferon
and cytokine transcriptional profiles
We used microarray analysis to determine whether the host
transcriptional response to infection would provide insight into the
differences in pathology and disease outcome observed for the
1918 and VN/1203 viruses. Our analyses revealed both
similarities and differences in the transcriptional response to
infection. For example, we found that the expression of type I
interferon stimulated genes was up-regulated in response to both
viruses as early as the 12-h time point, and the expression of these
genes remained elevated at 24 and 48 h p.i. (Figure 4A). However,
the 1918 virus elicited a stronger activation of these genes at 12 h
p.i., but by 24 and 48 h p.i. this activation was higher with the
VN/1203 virus (Table S1). ISG15 was one of the genes highly
activated during infection with both viruses. It has been shown
that ISG15 has antiviral activities against HIV-1 and Ebola
Figure 1. The 1918 virus causes greater early tissue damage than VN/1203 at 24 hours p.i. Panels A, C, E show 1918 infected monkey
tissues at 24 hours p.i. Panels B, D, F show VN/1203 infected monkey tissues at 24 hours p.i. A. Peribronchiolar alveoli showed severe alveolitis,
edema, and hemorrhage. Bar=100 mm. B. Mild peribronchitis was observed, but alveoli were clear preserving air space. Bar=100 mm. C. Large
amounts of viral antigen were detected at bronchial epithelium in 1918 virus infected monkey lungs. Bar=100 mm. D. Small amounts of viral antigens
positive cells at bronchial epithelium in VN1203 virus infected monkey lungs. Bar=100 mm. E. Large amounts of viral antigens at alveoli in 1918 virus
infected monkey lungs. Bar=50 mm. F. Scattered viral antigen positive cells at alveoli in VN1203 infected monkey lungs. Bar=50 mm.
doi:10.1371/journal.ppat.1000604.g001
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more, ISG15 targets a wide variety of cellular pathways
[26,27,28,29,30]. Consequently depending on the conjugation of
ISG15, this could alter the host antiviral response or may impair
viral replication.
We also analyzed the expression of selected chemokine and
cytokine genes and again found a similar pattern of expression
with a small transient difference at 24 h p.i. (Figure 4B). During
our analysis we found that CXCL10 and CXCL11 were among
the most highly induced chemokine genes during infection with
both viruses. This illustrates a scenario where T cells are tethered
to sites of inflammation at very early stages of infection [31]. A
detailed listing of these genes and their change in expression can
be found in Table S2. These results are consistent with our
previous findings that both viruses elicit transcriptional induction
of interferon- and cytokine-associated gene expression [8,9].
However, even though the present direct comparison of the host
response to these viruses indicates that the 1918 virus elicits a
somewhat stronger induction of interferon-stimulated gene
expression, it is unlikely that differences in this response alone
would have a major impact on disease outcome.
The 1918 and VN/1203 viruses differentially regulate the
expression of inflammation and cell death related genes
Our analyses also revealed groups of genes that were regulated
differently by the two viruses. T-test analysis of individual time
points indicated that there were 55, 428, and 68 genes that were
differentially regulated by the two viruses at 12, 24, and 48 h p.i.,
respectively. Functional analysis of these genes indicated that the
majority were grouped into the categories of inflammatory disease,
immune response, and cell death (Table 1). Because the greatest
differences in the host response occurred at 24 h p.i, we focused
our analyses at this time point. Figure 5A shows a heat map of the
428 genes that were differentially regulated at 24 h p.i. Notably,
many of these genes were up-regulated in the bronchus of 1918
virus infected animals but down-regulated in animals infected with
VN/1203. This included numerous genes associated with the
inflammatory response and cell death pathways. Expression of
selected genes was verified by RT-PCR (Figure S4).
Because the largest number of gene expression differences
elicited by the two viruses was associated with the inflammatory
response, we used Ingenuity Pathways Analysis to evaluate this
response in greater depth and to visualize the interconnections
between individual genes. This software analyzes gene expres-
sion data in the context of known biological response and
regulatory networks as well as other higher-order response
pathways. A network of differentially expressed genes associated
with the inflammatory response is shown in Figure 5B. In this
Figure, genes depicted in blue were up-regulated by the 1918
virus but down-regulated by VN/1203 virus, whereas genes
depicted in green were up-regulated by both viruses. Of
particular note was the differential regulation of NLRP3
(nucleotide-binding domain and leucine-rich-repeat-containing
protein 3) and IL-1b, key components of the inflammasome, a
recently described component of the innate immune response to
influenza A virus [32,33,34]. Verification of IL1b and NLRP3
expression are provided in Figure S5. By 24 h p.i. the 1918 virus
elicited the up-regulation of these genes; however they were both
down-regulated during VN/1203 infection. In addition, only the
1918 virus elicited the increased expression of TNF-a,ak e y
Figure 2. Macaques infected with the VN/1203 virus recovered from infection at 16 days p.i. Tissue regeneration and lymphocyte
infiltration in mildly affected lung lobe containing prominent peribronchiolar lymph follicles development. Bar=200 mm.
doi:10.1371/journal.ppat.1000604.g002
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the transcriptional regulation of this network of inflammatory
genes may have a significant impact on eventual disease
outcome.
The 1918 and VN/1203 viruses elicit differences in the
timing and extent of apoptosis after infection
Our gene expression analyses also revealed that the 1918 and
VN/1203 viruses perturbed the expression of genes associated
Figure 3. The 1918 virus overcomes the host response but not the VN/1203 virus. Virus titers were determined in plaque assays of bronchi
homogenates at 12, 24 and, 48 h p.i. in animals infected with the 1918 and VN/1203 viruses, as well as 3 and 6 days p.i. in animals infected only with
the VN/1203 virus. Each bar graph represents an individual measurement of viral load. Each individual animal (represented by the letters A to J) shows
two measurements (left and right bronchi). Open bars in the 1918 virus titers graph at 3 and 6 days post infection were incorporated from Kobasa et
al [8] for reference. Line graph shows the average of the four measurements per time point (two samples per animal, two animals per time point).
doi:10.1371/journal.ppat.1000604.g003
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of gene expression associated with this response. We therefore
sought to verify the presence of apoptotic cells by using the
TUNEL assay in infected lung and bronchus. This assay revealed
desquamated and apoptotic cells at the sites of inflammatory
lesions as well as phagocytes containing cells undergoing apoptosis
(Figure 6 and S3). In tissues from animals infected with the 1918
virus, there was evidence of apoptosis at 12 h p.i., but the level of
TUNEL staining diminished markedly at later time points. In
contrast, in tissues from animals infected with VN/1203, there was
little evidence of apoptosis at 12 h p.i, but greater evidence of
apoptosis was observed at the 24- and 48-h time points. These
results indicate that both viruses elicited an apoptotic response in
the lung and bronchus, but that the 1918 virus elicited an earlier
response that later diminished, whereas VN/1203 elicited a
comparatively delayed apoptotic response that was then main-
tained through the 48-h time point. Therefore, the timing and
Figure 4. The 1918 and VN/1203 viruses elicit similar interferon and cytokine transcriptional profiles. Microarray analysis of 1918 and VN/
1203 virus infected macaque bronchi at 12, 24 and 48 h p.i. A, Expression of type I interferon stimulated genes. B, expression of chemokines and
cytokinesrelatedgenes.Genesshowninyellowwereup-regulatedandthoseinblueweredown-regulatedininfectedrelativetomock-infectedanimals.
doi:10.1371/journal.ppat.1000604.g004
Table 1. Number of specific genes differentially regulated by
1918 virus infected bronchi relative to VN/1203 infected
animals.
Function 12 h 24 h 48 h
Cell cycle 10 29 8
Cell death 22 107 19
Cellular growth and proliferation 18 113 20
Hematological disease 9 77 10
Immune response 6 107 13
Immunological disease 10 86 13
Infectious disease 1 39 3
Inflammatory disease 14 81 13
Respiratory disease 10 29 3
doi:10.1371/journal.ppat.1000604.t001
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PLoS Pathogens | www.plospathogens.org 7 October 2009 | Volume 5 | Issue 10 | e1000604Figure 5. The 1918 and VN/1203 viruses differentially regulate the expression of inflammation and cell death related genes. (A)
Venn diagram analysis was performed on the set of 428 genes that were differentially regulated by both viruses at 24 h p.i. All infected samples were
compared to genotype-matched mock-infected samples via microarray analysis. Replicate samples were then pooled and error-weighted in silico.
These genes were up-loaded into Ingenuity Pathway Analysis and categorized into functional categories that are included to the right of the heat
map. (B) Biological network analysis of the top two functional categories: immune response (p-value=2.42E-22) and inflammatory response (p-
value=1.16E-16) determined by Ingenuity Pathway Analysis. This analysis highlights a subset of genes that were up-regulated by both viruses (green
shading) and a subset of genes that were anti-coregulated, that is up-regulated during 1918 infection but down-regulated during VN/1203 infection
(blue shading). Boxed genes in the diagram highlight the anti-coregulation of the inflammasome components NLRP3 and IL-1b respectively. Included
heat map illustrates the expression of IL1b and NLRP3. Yellow color indicates up regulation, blue indicates down regulation.
doi:10.1371/journal.ppat.1000604.g005
Genomic Analysis of 1918 and H5N1 Influenza Virus
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also have a significant impact on disease outcome.
Discussion
The 1918 Spanish Flu pandemic was the deadliest infectious
disease outbreak on record, and avian H5N1 influenza viruses
have proven to be highly virulent in cases of human infection. To
determine if there are differences in the host response to these two
highly pathogenic influenza viruses, we performed extensive
genomics analysis of bronchus tissue isolated from macaques
infected with either the 1918 or VN/1203 viruses. We investigated
the global transcriptional changes in bronchi, a lower respiratory
tissue, rather than lungs because of the overwhelming cell
infiltration that occurs in the lungs during influenza virus infection.
Additionally, there was substantial replication of both viruses in
this tissue. Our analyses revealed that these viruses elicited similar
transcriptional profiles for interferon and cytokine genes, but
markedly different transcriptional profiles for genes associated with
inflammation and apoptosis. Our results depict a scenario where
early during infection there was an accelerated up-regulation of
the inflammasome by the 1918 virus in addition to the numerous
cell death related genes that were up-regulated during infection
with the 1918 virus but down-regulated during VN/1203
infection. These events represent important differences in the host
response to these viruses and likely contribute to the severity and
lethality of disease associated with 1918 virus infection.
Our previous study comparing macaque host responses to 1918
and A/Kawasaki/173/01 viruses showed that late after infection
(3, 6 and 8 days) severity of tissue damage and fatal outcome was
due to dysregulation of the antiviral response [8]. That study
suggested that critical decisions influencing the outcome of the
infection may occur very early. In this study, our results suggest
that events taking place as early as 24 h after infection likely
contribute to severity of tissue damage and lethal outcome during
1918 virus infection. For example, the 1918 virus elicited the
increased expression of genes encoding NLRP3 and IL-1b, key
components of the inflammasome, while these genes were being
down-regulated by the VN/1203 virus. This finding suggests that
an accelerated or excessive activation of the inflammasome is
Figure 6. The 1918 and VN/1203 viruses elicit differences in the timing and extent of apoptosis after infection. TUNEL assay in fixed
bronchi infected either with 1918 (panels A, B and C) or VN/1203 (panels D, E and F) viruses at 12, 24 and 48 h p.i. Positive cells (brown color) were
desquamated and inflammatory cells. Additionally many phagocytes contained cells positive for apoptosis.
doi:10.1371/journal.ppat.1000604.g006
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early activation of NLRP3 and IL-1b production results in the
infiltration of neutrophils and monocytes to the sites of infection
where these cells continue to secrete cytokines resulting in a
‘‘cytokine storm’’. Furthermore, Baskin et al. showed that VN/
1203 infection of macaques was characterized by extensive tissue
damage, an excessive and sustained type I interferon response, and
innate immune induction [9]. Our present results also showed that
VN/1203 caused significant pathology, but that 1918 infection
generated more severe and sustained tissue damage. The study by
Baskin et al. also compared the host response of VN/1203
infection to recombinant viruses containing two or three genes of
the 1918 virus, whereas the present comparisons were performed
using the fully reconstructed 1918 pandemic virus.
It is interesting to note that the virulence of these two viruses in
macaques is somewhat different than in mouse models of infection.
In the macaque model, the 1918 virus causes a lethal infection,
whereas VN/1203 causes severe but typically non-lethal disease.
In contrast, in the mouse model the avian VN/1203 virus is more
pathogenic than the 1918 virus and is capable of causing disease
and death at a much lower infectious dose. However, global
transcriptional analysis of lung tissue from mice infected with the
1918 virus also revealed enhanced inflammatory and cell death
responses that remained unabated until death [7]. Therefore, data
from the mouse infection model also indicates a clear difference in
the host response to 1918 and VN/1203 virus infection.
In addition to discovering significant differences in the
inflammatory response elicited by the 1918 and VN/1203 viruses,
we also identified notable differences in the apoptotic response
induced by these viruses. Even though many studies have shown
that influenza virus infection induces apoptosis, there are still
contradicting reports about the induction and biological conse-
quences of this response. For example, ectopic expression of the
viral NS1 protein induces apoptosis [35]. In contrast, a NS1
deletion mutant has been shown to be a stronger inducer of
apoptosis than the wild-type virus [36]. Regarding the conse-
quences of the response, in vitro studies have demonstrated that
expression of the anti-apoptotic protein Bcl2 results in impaired
influenza virus production [37]. Caspase inhibitors also impair the
propagation of influenza virus, possibly due to the nuclear
retention of viral ribonucleoprotein (RNP) complexes [38].
Caspases may regulate the export of RNPs by increasing the
diffusion limit of nuclear pores, thus allowing the passive diffusion
of larger proteins [39]. Consequently, early during infection RNPs
are transported out of the nucleus via an active export mechanism.
As viral infection progresses and caspase activity increases cellular
proteins are destroyed, thereby compromising the export of viral
proteins. However, widening of nuclear pores may allow viral
RNPs to use an alternative mode of exit from the nucleus thereby
supporting viral replication. It has been suggested that this may
allow influenza virus to take advantage of host cell antiviral
responses to support viral replication [40].
Despite these apparent contradictions, differences in the
activation of cell death pathways could help to explain the
patterns of virus titers observed in our study. For example, the
increase in apoptosis observed in the VN/1203 infected tissues
(Figure 6, panels E, F) at the 48-h time point could result in less
viral progeny as a consequence of cell death. In contrast, in the
tissues infected with the 1918 virus, apoptosis decreased over time
(Figure 6, panels A–C), which may ultimately provide a more
favorable environment for the generation of additional viral
progeny. The timing and extent of the apoptotic response elicited
by these two viruses may therefore have a significant impact on
eventual disease outcome.
We also found that a number of genes differentially regulated
during 1918 virus infection were associated with cellular growth
and proliferation and cell-cycle regulation (Table 1). The 1918
virus may take advantage of the altered expression of these host
factors for utilization during its life cycle. In vitro experiments have
demonstrated that nuclear extracts from uninfected cells increase
influenza RNA synthesis as well as that of ectopically expressed
virion RNPs, suggesting that cellular factors are involved in the
switch between mRNA transcription and genome replication [41].
For example, RAF1 (RNA polymerase activating factor 1;
identical to HSP90) appears to associate with the viral PB2
protein. This interaction may facilitate the association of unbound
polymerase with RNA template, which could affect the interaction
between PB1 and PB2 and therefore modulate the polymerase
complex [42,43,44]. The involvement of host factors during the
various stages of the viral life cycle is poorly understood and is the
subject of major efforts to decipher the complex virus-host
interactions that determine the outcome of infection.
In summary, our findings suggest that differential changes in the
expression of inflammatory and cell death related genes as early as
12 to 24 h after infection likely contribute to the severity and lethal
outcome of 1918 virus infection. Specifically, the accelerated up-
regulation of the inflammasome components NLRP3 and IL-1b,
as well as TNF-a, elicited by the 1918 virus may enhance
neutrophil and monocyte infiltration and generate a strong
antiviral response that will be detrimental rather than protective
to the host. These findings may have therapeutic implications,
suggesting that drugs that limit the inflammatory response may
help to reduce the lung pathology associated with severe influenza
virus infection.
The feasibility of such approach has been recently demonstrated
by Aouadi et al. [45], who showed that silencing of the Map4k4
kinase in macrophages by oral delivery of b1,3-D-glucan-
encapsulated siRNA particles protected mice from lipopolysac-
charide-induced lethality by inhibiting TNF-a and IL-1b produc-
tion. In addition, Marsolais et al. [46] showed that local
administration of the sphingosine analog AAL-R to mouse airways
significantly decreased the release of a variety of cytokines and
chemokines known to contribute to the cytokine storm effect,
resulting in less cytopathology of alveolar cells and inflammatory
driven congestion of air spaces. Finally, Aldridge et al. [47]
reported that decreased trafficking of a specific subset of dendritic
cells by treatment with the peroxisome proliferator-activated
receptor-agonist pioglitazone reduced morbidity and mortality
associated with highly pathogenic influenza A virus infection.
Thus, drugs that limit the early inflammatory response may be of
particular benefit in treating infections caused by highly
pathogenic influenza viruses.
Supporting Information
Figure S1 Histopathology examination of bronchi and alveoli
infected with recombinant 1918 and VN/1203 virus at 12 hours
post infection. Panels A and B showing bronchial images.
Bar=200 mm. Panels C and D showing alveolar images.
Bar=50 mm. A, 1918 virus-infected bronchi showed viral antigen
expression along the terminal bronchiole and respiratory bron-
chiole (arrows). B, VN1203 virus-infected bronchi showed viral
antigen expression along the terminal bronchiole and respiratory
bronchiole. C, positive cells were cuboidal cells lining the junction
between the ciliated epithelia and alveolar cells. In addition,
plump-shaped alveolar cells at the peribronchiolar alveolus were
positive for antigens. D, positive cells were bronchiolar cells at the
bronchiolar/alveolar junction, plump-shaped type II alveolar cells
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alveolus are indicated.
Found at: doi:10.1371/journal.ppat.1000604.s001 (4.89 MB TIF)
Figure S2 Histopathology examination of bronchi and alveoli
infected with recombinant 1918 and VN/1203 virus at 48 hours
post infection. Panels A and B showing bronchiolar images; C and
D showing alveolar images. Bar=50 mm. A, viral antigens were
detected at the bronchiolar area and the peribronchiolar alveolus.
B, viral antigens were detected at the bronchiolar area and the
peribronchiolar alveolus. C, both plump and linear antigen-
positive cells were detected. D, many linear-shaped, antigen-
positive type I cells were detected in the edematous lesions.
Found at: doi:10.1371/journal.ppat.1000604.s002 (4.84 MB TIF)
Figure S3 The 1918 and VN/1203 viruses elicit differences in
the timing and extent of apoptosis after infection of macaque lungs
early during infection. TUNEL assay in fixed lungs infected either
with 1918 (panels A, B and C) or VN/1203 (panels D, E and F)
virus. Positive cells (brown color) were desquamated and
inflammatory cells, additionally many phagocytes contained
apoptosis positive cells.
Found at: doi:10.1371/journal.ppat.1000604.s003 (3.58 MB TIF)
Figure S4 Bar graph showing the expression of selected genes.
Quantitative real-time PCR (Taqman) analysis of selected genes
detected in macaque infected bronchi.
Found at: doi:10.1371/journal.ppat.1000604.s004 (0.48 MB TIF)
Figure S5 Bar graph showing the expression of NLRP3 and
IL1b genes. Quantitative real-time PCR (Taqman) analysis of
selected genes detected in macaque infected bronchi.
Found at: doi:10.1371/journal.ppat.1000604.s005 (0.43 MB TIF)
Table S1 Ingenuity Pathway Analysis: Interferon type I
regulated genes changed $2 fold compared to mock (p#0.01)
Found at: doi:10.1371/journal.ppat.1000604.s006 (0.07 MB PDF)
Table S2 Ingenuity Pathway Analysis: Chemokine and cytokine
related genes changed $2 fold compared to mock (p#0.01).
Found at: doi:10.1371/journal.ppat.1000604.s007 (0.07 MB PDF)
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